Correction: Wanderer et al. The Role of Losartan as a Potential Neuroregenerative Pharmacological Agent after Aneurysmal Subarachnoid Haemorrhage. Int. J. Mol. Sci. 2020, 21, 6496
Stefan Wanderer, Lukas Andereggen, Jan Mrosek, Sepide Kashefiolasl, Serge Marbacher, Jürgen Konczalla
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsIntracranial Aneurysms: Treatment and Complications · Traumatic Brain Injury and Neurovascular Disturbances · Neurosurgical Procedures and Complications
Error in Figure
In the original publication [1], there was a mistake in Figure 4A as published. Unintentionally, the authors chose the same image as that published in Acta Neurochir (Wien). November 2016;158(11):2075–2083. Doi:10.1007/s00701-016-2939-5. Epub 10 September 2016. The corrected Figure 4A appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor.
The authors apologize for the mistake and declare again that the conclusion is accurate.
Macroscopic assessment of the brain in the sham and SAH groups. (A) shows the sham brain; no signs of subarachnoid bleeding patterns were detected. (B) shows the SAH brain with clear blood clots in the basal cisterns.
The reference list from the paper itself. Each links out to its DOI / PubMed record.